Enhancement of Macular Pigment Density by Oral Lutein Supplementation

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
The primary objective of EMPOLS is an increase in macular pigment density (MPD) and contrast sensitivity (CS) after six months supplementation of oral non-compound ester Lutein 10 mg daily, contained in VitaluxPlus®.
Epistemonikos ID: aa4db15c60d9cdc84bedf7745e6cc778cfbcb6e1
First added on: May 04, 2024